Publications
2009
TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia.
Lagler H,
Sharif O,
Haslinger I,
Matt U,
Stich K,
Furtner T,
Doninger B,
Schmid K,
Gattringer R,
de Vos AF,
Knapp S.
J Immunol, 2009 Aug;183(3): 2027-36. Epub 2009 Jul 13.
2009
Peptide Bbeta (15-42) preserves endothelial barrier function in shock.
Gröger M,
Pasteiner W,
Ignatyev G,
Matt U,
Knapp S,
Atrasheuskaya A,
Bukin E,
Friedl P,
Zinkl D,
Hofer-Warbinek R,
Zacharowski K,
Petzelbauer P,
Reingruber S.
PLoS ONE, 2009;4(4): e5391. Epub 2009 Apr 29.
2008
From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infection.
Sharif O,
Knapp S.
Immunobiology 2008, 213, 701–713.
2008
Lipoteichoic Acid-induced Lung Inflammation depends on TLR2 and the concerted action of TLR4 and Platelet-activating Factor Receptor.
Knapp S,
von Aulock S,
Leendertse M,
Haslinger I,
Draing C,
Golenbock DT,
van der Poll T.
Journal of Immunology 2008, 180: 3478–3484.
2008
Structural coupling of Fes and Abl SH2-tyrosine kinase domains links substrate recognition and kinase activation.
Filippakopoulos P,
Kofler M,
Hantschel O,
Gish GD,
Grebien F,
Salah E,
Neudecker P,
Kay LE,
Turk BE,
Superti-Furga G,
Pawson T,
Knapp S.
Cell. 2008 Sep 5;134(5): 793–803.
2007
2007
Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo.
Knapp S,
Matt U,
Leitinger N,
van der Poll T.
J Immunol. 2007, 178:993–1001.
2007
Anakinra in two adolescent female patients suffering from colchicineresistant familial Mediterranean fever: effective but risky.
Gattringer R,
Lagler H,
Gattringer KB,
Knapp S,
Burgmann H,
et al.
Eur J Clin Invest. 2007, 37:912–914.
2007
CD14 facilitates invasive respiratory tract infections by Streptococcus pneumoniae.
Dessing M,
Knapp S,
Florquin S,
de Vos AF,
van der Poll T.
Am J Respir Crit Care Med. 2007, 175:604–611.
